跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
HUMIRA adalimumab 40 mg/0.4 mL solution for injection pre-filled pen - TGA Drug Approval Details
Approvals
/
TGA
/
HUMIRA adalimumab 40 mg/0.4 mL solution for injection pre-filled pen
Approved
STANDARD
HUMIRA adalimumab 40 mg/0.4 mL solution for injection pre-filled pen
AbbVie Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
72b49b6ce07661d7
Company
AbbVie Pty Ltd
Type
Standard
Approval Details
Approval Id
72b49b6ce07661d7
Product Name
HUMIRA adalimumab 40 mg/0.4 mL solution for injection pre-filled pen
Artg Id
281509
Artg Name
HUMIRA adalimumab 40 mg/0.4 mL solution for injection pre-filled pen
Sponsor
AbbVie Pty Ltd
Company Detail Path
/organization/abbvie-pty-ltd
Artg Date
2017-11-16
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2021-CMI-01077-1
Product Information
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2010-PI-03779-3
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
72b49b6ce07661d7
Type
Standard
Back to TGA Approvals